Impairment of STAT activation by IL-12 in a patient with atypical Mycobacterial and Staphylococcal infections

Keyphrases

• Interleukin-12 (IL-12) 100%
• Staphylococcal Infections 100%
• Atypical Mycobacteria 100%
• STAT Activation 100%
• STAT4 30%
• Interleukin-2 20%
• Lymphocytes 20%
• IL-12 Signaling 20%
• T Cells 10%
• Immune Response 10%
• Staphylococcus Aureus 10%
• Etiology 10%
• Intracellular Infection 10%
• Salmonella Infection 10%
• Interleukin-15 (IL-15) 10%
• Functional Response 10%
• Adverse Drug Reaction 10%
• Signaling Complex 10%
• Increased Vulnerability 10%
• Cytokine Signaling 10%
• Cytolytic Activity 10%
• Extracellular Signal-regulated Kinase 10%
• Sinusitis 10%
• IFN Production 10%
• Mycobacterium Intracellulare 10%

Immunology and Microbiology

• STAT4 100%
• Lymphocyte 66%
• STAT1 66%
• Cytokine Signaling 33%
• Drug Hypersensitivity 33%
• Immune Response 33%
• Mycobacterium avium 33%
• Salmonella 33%
• T Cell 33%
• Wild Type 33%
• Staphylococcus Aureus 33%
• Interleukin 15 33%
• Sinusitis 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Staphylococcal Infection 100%
• Atypical Mycobacteriosis 100%
• Adverse Drug Reaction 33%
• Infection 33%
• Phosphotransferase 33%
• Cytokine 33%
• Absence 33%
• Staphylococcus Aureus 33%
• Interleukin 15 33%
• Sinusitis 33%
• Salmonellosis 33%